Commercial real estate broker David Choate looks back on 35-year career
NH Business Review interviewed Choate at the International Marketplace, located at the Pease International Tradeport, where Choate helped negotiate many deals over the years.
Bentley sees flat earnings
Bentley Pharmaceuticals announced second-quarter earnings similar to those it turned in for the second quarter last year.
The Exeter-based company said it earned $2.6 million, or 12 cents a diluted share, for the quarter — about the same as the second quarter last year. But if comparable accounting systems were used for both years, the company’s profit increased by more than $700,000.
The generic drug supplier – which sells most of its products in Europe, primarily Spain – also increased it sales to nearly $29 million, about $4 million more than last quarter. The would bring the company’s total sales to $57 million for the first half of the year, with net income of almost $3.8 million.
In order to expand its sales force in Europe, Bentley invested some $7 million in capital additions during the first half of the year there, the company reported. – BOB SANDERS
